Name: Gyre Therapeutics, Inc. (CBIO) Balance Sheet
Creator: FinSpry

Gyre Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Gyre Therapeutics, Inc. (CBIO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	34.77	41.79	47.87	90.25	137.04	158.20	209.92
Cash & Short-Term Investments	34.77	41.79	47.87	90.25	137.04	158.20	209.92
Accounts Receivable	0.14	0.00	0.00	0.00	0.00	0.00	0.41
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.04	0.15	0.29	0.00	0.00	0.00	0.00
Total Current Assets	34.80	43.79	50.71	90.79	138.27	162.53	212.27
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.77	0.75	1.95	2.95	3.01	0.96
Other Non-Current Assets	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.81	1.37	0.80	3.51	4.51	4.57	2.57
Total Assets	35.62	45.32	51.81	94.35	142.83	167.97	214.84
Current Liabilities
Accounts Payable	0.11	6.09	7.96	10.82	11.53	10.15	8.28
Short-Term Debt	0.07	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	9.45	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	0.06	0.00	0.00	0.00	0.26	0.00	0.00
Total Current Liabilities	9.61	6.84	8.88	11.82	12.43	10.95	8.76
Non-Current Liabilities
Long-Term Debt	37.48	0.07	0.00	0.92	1.92	2.82	0.00
Other Non-Current Liabilities	4.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	41.48	0.07	0.00	0.92	1.92	2.87	0.61
Total Liabilities	47.10	6.90	8.88	12.74	14.61	13.77	9.37
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-17.87	-456.49	-419.59	-372.90	-309.47	-258.44	-200.55
Additional Paid-in Capital	499.61	494.84	462.46	454.45	437.64	412.60	405.97
Shares Outstanding	19.50	0.00	0.00	0.00	0.00	0.00	0.00
Total Stockholders' Equity	-11.48	38.41	42.93	81.60	128.22	154.20	205.46
Total Liabilities & Equity	11.09	45.32	51.81	94.35	142.83	167.97	214.84